Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular TherapyMohamed A. Kharfan‐Dabaja, Marcie Riches, Sonali Chaudhury et al.|Transplantation and Cellular Therapy|2021Cited by 180
Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysisScott Goldsmith, Marcie Riches, Muhammad Bilal Abid et al.|Blood|2021Cited by 177
Updated Trends in Hematopoietic Cell Transplantation in the United States with an Additional Focus on Adolescent and Young Adult Transplantation Activity and OutcomesRachel Phelan, Mukta Arora, Min Chen et al.|Transplantation and Cellular Therapy|2022Cited by 82
Real-World Data Showing Trends and Outcomes by Race and Ethnicity in Allogeneic Hematopoietic Cell Transplantation: A Report from the Center for International Blood and Marrow Transplant ResearchJeffery J. Auletta, Bronwen E. Shaw, Jianqun Kou et al.|Transplantation and Cellular Therapy|2023Cited by 68
Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donorsMichael A. Pulsipher, Thomas R. Spitzer, Brent R. Logan et al.|Haematologica|2018Cited by 22